All Curated Mutation Sites in EBV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

EBNA-3B/EBNA-3C

Keyword: BMRF1

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	20926567	R256E	BMRF1	BMRF1	Cell line		View
2	20926567	C206E	BMRF1	BMRF1	Cell line		View
3	20926567	C95E	BMRF1	BMRF1	Cell line		View
4	20926567	H141F	BMRF1	BMRF1	Cell line		View
5	20926567	K19E	BMRF1	BMRF1	Cell line		View
6	20926567	K29E	BMRF1	BMRF1	Cell line		View
7	20926567	R87E	BMRF1	BMRF1	Cell line		View
8	20926567	K99E	BMRF1	BMRF1	Cell line		View
9	31481499	G217V	BMRF1	BMRF1	Immunoblastic Lymphadenopathy		View
10	31481499	E300G	BMRF1	BMRF1	Nasopharyngeal Carcinoma		View
11	31481499	F86S	BMRF1	BMRF1	Nasopharyngeal Carcinoma		View
12	31481499	V232L	BMRF1	BMRF1	Nasopharyngeal Carcinoma Immunoblastic Lymphadenopathy Stomach Neoplasms		View
13	19801550	H141F	BMRF1	BMRF1		R	View
14	19801550	R87E	BMRF1	BMRF1		R	View
15	19801550	C95E	BMRF1	BMRF1		R	View
16	19801550	C206E	BMRF1	BMRF1		R	View
17	19801550	K19E	BMRF1	BMRF1		R	View
18	19801550	K99E	BMRF1	BMRF1		R	View
19	19801550	R256E	BMRF1	BMRF1		R	View
20	19801550	K29E	BMRF1	BMRF1		R	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.